Chemomab Therapeutics Ltd. American Depositary Share Stock Performance

Open $2.81	Prev. Close $2.67	Circuit Range N/A
Day Range $2.66 - $2.87	Year Range $1.39 - $3.53	Volume 2,650
Average Traded $2.82

Chemomab Therapeutics Ltd. American Depositary Share Share Price Today

As of 20 September 2026, Chemomab Therapeutics Ltd. American Depositary Share's share price is $2.63. The stock opened at $2.81, compared to its previous close of $2.67. During today's trading session, Chemomab Therapeutics Ltd. American Depositary Share's share price traded between $2.66 and $2.87, with an average price of $2.77. Over the past 52 weeks, the stock has recorded a high of $3.53 and a low of $1.39. In terms of performance, Chemomab Therapeutics Ltd. American Depositary Share's share price has risen by 75.00% over the last six months and is down 2.05% on a year-on-year basis.

Chemomab Therapeutics Ltd. American Depositary Share Share Price Chart

$2.66$2.87

Chemomab Therapeutics Ltd. American Depositary Share Stock Fundamentals & Key Indicators

Market Cap $597.42M	PE Ratio (TTM) 21.88	Dividend Yield N/A
EPS (TTM) $0.12	Revenue (TTM) N/A	Return On Equity (TTM) -76.32%
Profit Margin N/A	Debt to Equity 0.19	Quarterly Earnings Growth YoY -71.49%

Chemomab Therapeutics Ltd. American Depositary Share Quarterly Profit & Loss

All figures in USD

Particulars	Mar 2022	Jun 2022	Sep 2022	Mar 2023
Revenue	N/A	N/A	N/A	N/A
Net Profit	-$5.10M	-$6.19M	-$8.08M	-$8.75M
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-21.28%	-30.53%	-8.33%

Chemomab Therapeutics Ltd. American Depositary Share Annual Profit & Loss

All figures in USD

Particulars	2021	2022
Revenue	N/A	N/A
Net Profit	-$12.48M	-$27.65M
Net Profit Margin	N/A	N/A
Income Change	N/A	-121.56%

About Chemomab Therapeutics Ltd. American Depositary Share

Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is Nebokitug, a humanized monoclonal antibody attenuates the basic function of CCL24 that has completed phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC); and is in phase 2 clinical trial to treat systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.

Chemomab Therapeutics Ltd. American Depositary Share Historical Returns

Month	Open	Close	Change %
Sep 2026	$2.70	$2.66	-1.12%
Aug 2026	$1.60	$2.69	+74.68%
Jul 2026	$1.73	$1.54	-3.14%
Jun 2026	$2.00	$1.59	-20.70%
May 2026	$1.57	$2.00	+35.47%
Apr 2026	$1.58	$1.48	-1.33%
Mar 2026	$1.85	$1.50	-15.73%
Feb 2026	$1.58	$1.78	+14.84%
Jan 2026	$1.76	$1.55	-5.49%
Dec 2025	$2.64	$1.64	-36.80%
Nov 2025	$3.00	$2.60	-15.88%
Oct 2025	$2.65	$3.08	+15.11%

CMMB Share Price FAQs

What is Chemomab Therapeutics Ltd. American Depositary Share share price today?

Chemomab Therapeutics Ltd. American Depositary Share share price today is $2.63 as on September 19, 2026 at 12:51 am IST.

What is the 52 week high and 52 week low of Chemomab Therapeutics Ltd. American Depositary Share stock?

The 52 week high of Chemomab Therapeutics Ltd. American Depositary Share stock is $3.53, while the 52 week low is $1.39 as of 19 Sep '26.

What is CMMB's market capitalisation today?

CMMB market capitalisation is $597.42M as of September 20, 2026, at 1:41 am IST.

What is CMMB's net income for the last quarter?

CMMB's net income for the last quarter is -0.01B USD.

What is the 5 year returns of CMMB?

The 5 year returns of CMMB is -76.37% as on 19 Sep '26.

What is the high & low stock price of CMMB today?

CMMB stock price hit a high of $2.87 and low of $2.66 as of 19 Sep '26.

Can I buy CMMB shares in India?

Yes. You can buy CMMB in India by opening an international trading account.